logo
Drunk Elephant Was Never for Kids

Drunk Elephant Was Never for Kids

Drunk Elephant has learned the hard way not to play with tweens.
On Monday, Japanese beauty conglomerate Shiseido released its first quarter 2025 earnings and revealed that sales at the pastel-hued clean beauty brand it acquired had declined by a staggering 65 percent. It was a major reversal of fortunes for Drunk Elephant, which Shiseido acquired for $845 million in 2019 and rose to fame for spearheading trends in accessibility to high-quality formulations, playful marketing and of course, liquid bronzer.
For those who have been closely observing, however, the news is simply confirmation of suspected stumbles.
Since it was purchased six years ago, Drunk Elephant grew slowly, then explosively, then shrunk, as it has struggled to hold on to consumers old and new while simultaneously balancing its playful sense of whimsy with its core promise of results-driven skincare. Unforeseen headwinds also set Drunk Elephant back, like overexposure to the weakening Chinese and travel retail segments, or production issues related to its best-selling Bronzing Drops.
But the main source of Drunk Elephant's woes is ever-fickle teenagers, who embraced it wholeheartedly during the height of the 'Sephora tween' phase last year before quickly moving on, exposing a gaping wound in its brand identity.
Prior to their arrival, the brand was a Sephora darling, quickly becoming its number one skincare brand after its in-store debut in 2015. By 2023, when the teens arrived, clamouring for Drunk Elephant's technicolor packaging, they brought a tailwind with them, helping the brand access a new and skin-curious audience.
But turning towards this new customer meant turning away from the brand's core: Millennials and young Gen-Xers, who were drawn to Drunk Elephant for its clean ethos and efficacious skincare. Now, they've come to see the brand as too young for their tastes.
'Drunk Elephant became so strongly associated with Sephora tweens that it lost credibility with older consumers,' explained Casey Lewis, who writes the teen trend newsletter After School. 'Tweens are notoriously fickle consumers. They're not brand loyal. They simply seek out what's new and trending, and when the market is as saturated as this one, consumers will literally never run out of other brands and products to try.'
A worsening economic climate has teens — and their parents — trading down from their beloved Protini peptide moisturisers ($69). Even the brand's creator may be moving on: Puck News recently reported that Tiffany Masterson, who founded the brand in 2013, is stepping down from her day-to-day duties as chief creative officer amid Drunk Elephant's sloppiest year yet. Shiseido declined to comment on speculation. The Curse of the Sephora Tweens
When the brand launched direct-to-consumer in 2013, it was positioned as clean, highly efficacious skincare with a winking sense of humour. Early hits, like its C-Firma Day Serum ($79), were seen as smart, better-priced alternatives to products like Skinceuticals CE Ferulic ($182). At a time when doctor-led labels were only slowly emerging, and the clean beauty movement was beginning to bloom, Masterson's brand resonated with a group of people who seemed to be waiting for it.
By 2019, Drunk Elephant was doing about $120 million in annuals sales. The next year, Shiseido touted its new acquisition as a key to increasing its profitability in the Americas, and went all-in on ramping up Drunk Elephant's distribution — in North American travel retail, in Sephora doors across China and in every Ulta Beauty in the US. As a result, sales nearly doubled, but they've since come back down: 2024 net sales hit just over $135 million, according to Shiseido.
The brand's influence in the greater industry has also waned significantly. Social chatter about Drunk Elephant cooled dramatically in the past year, down 72 percent, according to insights firm Spate. The brand peaked in January 2023 on the strength of its hyperviral Bronzing Drops, with interest dropping off at the beginning of last year. Even with a hit product, Drunk Elephant was unable to keep up with demand, which resulted in long sellout periods that allowed dozens of dupes (from Sephora neighbours like Saie, Glow Recipe and Westman Atelier) to fill the void. Since then, consumer interest in liquid bronzer has melted, with searches down 10 percent year on year, noted Addison Cain, Spate's senior insights and marketing lead.
Drunk Elephant's strengths remain in its serums and moisturisers, which once defined accessible and effective skincare but have since ceded that authority to competitively priced offerings from the Innbeauty Project or Isla Beauty, and even more affordable offerings from more Gen-Z-focussed brands like Byoma and Bubble.
Parents, for their part, are also souring on Drunk. 'I was super turned off that Drunk Elephant was marketing to my tween via TikTok influencers,' said Dora, a woman in her 40s, in The Business of Beauty's Instagram comments section. 'Not only did I refuse to buy her the 70$ [sic] moisturizer her 12 year skin did not need but I wasn't about to buy it for myself just so she could steal it.'
Drunk Elephant has never marketed directly to Gen-Z or -Alpha — executives have said so repeatedly — and its products have never been appropriate for young skin. (Its top selling Baby Facial, for instance, contains a cocktail of exfoliating acids that no dermatologist would recommend to a user under 18.)
'We're not going to start to try to get into a dialogue with children about acids and retinol,' founder Masterson told The Business of Beauty in 2024. In her mind, they're like alcoholic offerings on a restaurant menu: 'Parents decide whether or not that's appropriate for their kid.'
Still, in casting a too-wide net in reaching its target customer, the message that Drunk Elephant is fun for the whole family rose to the top.
Looking ahead, in Shiseido's integrated report for 2024, Barbara Calcagni, president of Nars and Drunk Elephant, stated the conglomerate's intent 'on regaining global momentum by increasing our loyal community and recruiting new customers.'
For its own sake, it could aim higher.
Sign up to The Business of Beauty newsletter, your complimentary, must-read source for the day's most important beauty and wellness news and analysis.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2
Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2

Business Insider

time2 hours ago

  • Business Insider

Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2

Billionaire investor David Tepper increased his stake in the struggling health insurance giant, UnitedHealth (UNH), during Q2. His move mirrors Warren Buffett 's Berkshire Hathaway (BRK.B), which also revealed a new $1.57 billion stake in UNH stock. Further, Michael Burry's Scion Asset Management bought calls on 350,000 shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. UNH stock gained 14% on Friday as bullish bets from Top hedge funds boosted investor hopes for a rebound. According to a recent 13F filing, Tepper's Appaloosa Management LP added 2.3 million shares of UNH, bringing the total value of the stake to $764 million. This makes UNH the fund's second-largest holding after Chinese e-commerce giant Alibaba (BABA). Tepper's bet comes at a turbulent time for UnitedHealth, which is dealing with a criminal probe into Medicare billing, a CEO shakeup, and the aftermath of a massive cyberattack. UNH stock has plunged about 40% year-to-date. Tepper Shifts Strategy on China Tepper's bet on UNH aligns with his investment strategy, which involves making bold bets on companies that others are avoiding. It is similar to his earlier investment in Chinese stocks, which he began buying last year when many investors were pulling back over economic and geopolitical concerns. It must be noted that those investments paid off as China's MSCI benchmark surged 46% over the past year due to Beijing's economic stimulus efforts. However, Tepper is now taking a more cautious approach. The fund reduced its holdings in major Chinese companies amid rising trade tensions. Appaloosa cut its stake in Alibaba by over 20% and also trimmed its positions in (JD), Baidu (BIDU), and PDD Holdings (PDD). Tepper's Other Bullish Bets Apart from UNH, the investor also ramped up his stake in Nvidia (NVDA), adding 1.45 million shares for a total of 1.75 million. This 483% increase brings the position's value to over $276 million. Also, he made some notable new investments last quarter. These include tech giant Intel (INTC), with 8 million shares valued at $179.2 million, and aerospace and defense company RTX (RTX), with 585,000 shares worth $85.4 million. The third-largest new buy is health information technology and clinical research provider IQVIA Holdings (IQV), with 300,000 shares valued at $47.3 million. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, four Holds, and two Sells assigned in the last three months. At $312.65, the average UnitedHealth stock price target implies a 2.17% upside potential.

Japanese auto giant aims to make Africa's richest country the hub of continental truck production
Japanese auto giant aims to make Africa's richest country the hub of continental truck production

Business Insider

time3 hours ago

  • Business Insider

Japanese auto giant aims to make Africa's richest country the hub of continental truck production

The South African arm of Japanese automaker Isuzu Motors is positioning itself as a manufacturing hub for commercial trucks on the continent Isuzu Motors South Africa plans to become Africa's hub for truck manufacturing to boost production and local sourcing. The company conducts discussions with Japan to relocate more commercial truck production to South Africa. Isuzu is targeting West Africa for scaling up truck exports and aims for 45% production localisation. The South African arm of Japanese automaker Isuzu Motors is positioning itself as a manufacturing hub for commercial trucks on the continent, part of a strategy to boost production volumes and deepen the use of locally sourced parts. Billy Tom, President and CEO of Isuzu Motors South Africa, told Reuters that he has been in discussions with Japan regarding the relocation of more production to Africa. Isuzu has already run successful trials of locally building truck bodies, though it still imports some from China and the Middle East. While export volumes for trucks remain small, Isuzu already ships pickups to more than 30 countries in Africa. Tom said the company is targeting West Africa as a starting point for scaling up truck exports. Isuzu has set an ambitious target to grow its African production volumes to 45%, up from about 15% six years ago and the current 22–23%. South Africa's auto industry, home to seven major manufacturers including Volkswagen, Toyota, and Mercedes-Benz ( faces mounting pressure from surging vehicle imports, particularly from China. Low domestic sales of locally assembled cars, coupled with sluggish local content levels, have already forced 12 company closures and wiped out more than 4,000 jobs in the past two years, Trade Minister Parks Tau said. The country produced 515,850 vehicles in 2024, well below the South African Automotive Masterplan 2035 target of 784,509. Adding to the pressure, South Africa's vehicle exports to the U.S. have collapsed this year, plunging 73% in the first quarter and falling even further, 80% in April and 85% in May, industry data shows.

‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock
‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock

Business Insider

time3 hours ago

  • Business Insider

‘Joyride Might Be Over,' Says Top Investor About Nvidia Stock

Nvidia (NASDAQ:NVDA) stock has built a reputation for consistently shattering quarterly earnings projections – a fact seasoned investors know all too well. But that winning streak can be a double-edged sword, as even a solid beat doesn't always translate into immediate post-earnings gains. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. That dynamic makes Nvidia's upcoming fiscal Q2 2026 earnings on August 27 especially intriguing. Momentum is already firmly in the bulls' corner, with NVDA shares up 91% since hitting a trough in early April. Expectations remain strong, though not at the triple-digit pace NVDA has delivered in its best quarters. The average analyst estimate of $45.75 billion points to year-over-year growth of 52.31%, with margins expected to hold at an impressive 72%. On paper, such results could still tempt investors to add shares ahead of the report – even if history suggests a short-term lull is possible afterward. But not everyone is convinced. One top investor, known as Oakoff Investments, is taking a far more cautious stance. 'I don't like the setup formed in NVDA's price action as it approaches the Q2 earnings release date,' warns the 5-star investor, who is among the top 4% of TipRanks' stock pros. Oakoff's caution stems largely from concerns about Nvidia's sales to China. While previous U.S. restrictions appear to have been lifted, there are signs the Chinese government may impose its own limits. That also possibility raises the stakes for Nvidia to deliver outsized growth in other regions to sustain investor enthusiasm – a task Oakoff believes is becoming increasingly difficult. 'If the market gets a slight hint towards further deterioration on this front, the stock may sell off badly even if NVDA beats the headline numbers as strongly as it did during the past 2 years,' Oakoff opined. Valuation is another sticking point. After months of gains, Oakoff argues the rally has been fueled by multiple expansion, pushing NVDA's Forward P/E ratio to an 'unsustainable' 42.5x. The result, according to Oakoff, is a setup vulnerable to disappointment. Given these risks, the investor is leaning toward profit-taking before the earnings call. 'I maintain a Hold rating, believing NVDA stock's high valuation and the new China uncertainty outweigh the likelihood of a strong Q2 beat,' Oakoff says. (To watch Oakoff Investments' track record, click here) Wall Street, in contrast, remains almost 'all in' on NVDA. With 35 Buys, 3 Holds, and a solitary Sell rating, the stock enjoys a Strong Buy consensus rating. (See NVDA stock forecast) To find good ideas for AI stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store